These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29385580)
21. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster. Nippert I; Schlegelberger B; Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871 [TBL] [Abstract][Full Text] [Related]
22. Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members. Finn KS; Pacyna J; Azevedo Tsou C; Jewel Samadder N; Sharp R Eur J Hum Genet; 2022 Jan; 30(1):53-61. PubMed ID: 33867528 [TBL] [Abstract][Full Text] [Related]
23. Women receiving news of a family BRCA1/2 mutation: messages of fear and empowerment. Crotser CB; Dickerson SS J Nurs Scholarsh; 2010 Dec; 42(4):367-78. PubMed ID: 21091619 [TBL] [Abstract][Full Text] [Related]
25. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220 [TBL] [Abstract][Full Text] [Related]
26. Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study. Daly MB; Montgomery S; Bingler R; Ruth K Fam Cancer; 2016 Oct; 15(4):697-706. PubMed ID: 26897130 [TBL] [Abstract][Full Text] [Related]
27. Communicating genetic risk information within families: a review. Wiseman M; Dancyger C; Michie S Fam Cancer; 2010 Dec; 9(4):691-703. PubMed ID: 20852947 [TBL] [Abstract][Full Text] [Related]
28. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Landsbergen K; Verhaak C; Kraaimaat F; Hoogerbrugge N Fam Cancer; 2005; 4(2):115-9. PubMed ID: 15951961 [TBL] [Abstract][Full Text] [Related]
29. The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program. Bunnell AE; Garby CA; Pearson EJ; Walker SA; Panos LE; Blum JL J Genet Couns; 2017 Feb; 26(1):105-112. PubMed ID: 27276934 [TBL] [Abstract][Full Text] [Related]
30. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Hallowell N; Ardern-Jones A; Eeles R; Foster C; Lucassen A; Moynihan C; Watson M Clin Genet; 2005 Jun; 67(6):492-502. PubMed ID: 15857416 [TBL] [Abstract][Full Text] [Related]
31. Family Communication in Inherited Cardiovascular Conditions in Ireland. Whyte S; Green A; McAllister M; Shipman H J Genet Couns; 2016 Dec; 25(6):1317-1326. PubMed ID: 27271705 [TBL] [Abstract][Full Text] [Related]
32. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. Dorval M; Patenaude AF; Schneider KA; Kieffer SA; DiGianni L; Kalkbrenner KJ; Bromberg JI; Basili LA; Calzone K; Stopfer J; Weber BL; Garber JE J Clin Oncol; 2000 May; 18(10):2135-42. PubMed ID: 10811679 [TBL] [Abstract][Full Text] [Related]
33. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not. Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844 [TBL] [Abstract][Full Text] [Related]
34. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406 [TBL] [Abstract][Full Text] [Related]
35. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia. Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518 [TBL] [Abstract][Full Text] [Related]
36. Professional challenges in cancer genetic testing: who is the patient? Chan-Smutko G; Patel D; Shannon KM; Ryan PD Oncologist; 2008 Mar; 13(3):232-8. PubMed ID: 18378533 [TBL] [Abstract][Full Text] [Related]
37. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633 [TBL] [Abstract][Full Text] [Related]
38. Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. Crawford B; Adams SB; Sittler T; van den Akker J; Chan S; Leitner O; Ryan L; Gil E; van 't Veer L Breast Cancer Res Treat; 2017 Jun; 163(2):383-390. PubMed ID: 28281021 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of laboratory perspectives on hereditary cancer panels. Stoll J; Weissman SM; Hook N; Selkirk C; Johnson AK; Newlin A; Vogel Postula KJ Fam Cancer; 2016 Oct; 15(4):689-96. PubMed ID: 26869169 [TBL] [Abstract][Full Text] [Related]